A Phase 4, Randomized, Double-masked, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of TEPEZZA? in Treating Patients with Chronic (Inactive) Thyroid Eye Disease
This Study is
No Longer Enrolling
Procedures include TEPEZZA infusions, blood draws, eye measurements. The trial lasts approximately 8-14 months and includes around 10-18 visits at the clinic.
MoreAdult
Initial diagnosis of thyroid eye disease for at least 3 years but less than 8 years Clinical Activity Score of 1 or less At least 3mm of proptosis (eye bulging) from patient's baseline or race/gender norms No previous eye muscle surgery, decompression surgery, or past treatment with TEPEZZA
Treatment
University of Colorado Hospital
Protocol Number: 20-2835
More information available at ClinicalTrials.gov: NCT04583735
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers